Tech

A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug

Enlarge (credit: Getty | Congressional Quarterly) The US Food and Drug Administration on Monday approved the antibody drug Aduhelm (generic name aducanumab) to treat Alzheimer’s disease. Aduhelm is the first new Alzheimer’s drug to earn FDA approval since 2003. It’s also the first drug to target a theoretical cause of the irreversible neurodegenerative disease—clumps of […]